The scientific focus adapted
to express the optimum potential
of your molecule

Marketing:
Unparalleled vision in metabolic disorders and risk assessment expertise for post-marketing studies and drug repositioning.

HeartArteryMacrophageLiverMusclePancreasAdipose Tissue

Preclinical development:
In-house predictive models and tracer technologies enable the generation of Proof of Concept efficacy data for your drugs.

Discovery:
Screening and lead validation utilize a dedicated research platform which combine with our focused scientific vision.

Home > News > Physiogenex to present its Diet-Induced NASH (DIN) hamster and Unx/salt-supplemented SDT fatty rat models at the World Congress on Insulin Resistance (WCIR) 2016

News detail

Return to all news & events

12/01/2016 Physiogenex to present its Diet-Induced NASH (DIN) hamster and Unx/salt-supplemented SDT fatty rat models at the World Congress on Insulin Resistance (WCIR) 2016

Physiogenex is proud to present its Diet-Induced NASH (DIN) hamster and Unx/salt-supplemented SDT fatty rat models at the World Congress on Insulin Resistance (WCIR) 2016, in Los Angeles, December 1st-3rd, 2016.

These  models will be presented by Dr. François Briand, Director of Research and Business Development, during the poster sessions.

If you want to set an appointment during the WCIR 2016 with Dr. François Briand and/or discuss about your NASH/Diabetic Nephropathy projects, please contact us !